Analysts Set Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Target Price at $17.75
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven research firms that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, three have given a buy recommendation and one […]
